Beijing, November 13, 2018 – 乔治临床( George Clinical ), a leading clinical research organization (CRO) in the Asia-Pacific region, has continued its involvement and collaboration with the Heart […]
了解更多
Increasingly, regulatory authorities are placing significant focus on clinical trial processes that ensure consistent, standardized, objective and unbiased reporting of safety and efficacy results; given that the definitions for many endpoint events include subjective components, and investigator-to-investigator subjective assessments may differ. Moreover, an increasing number of trials are now conducted in multiple geographies, and clinical […]
了解更多
The World Health Organization states that cardiovascular disease (CVD) has been the number one global cause of death; with an estimation of 17.5 million people dying from CVD in 20121, representing 31% of all global deaths. CVD has been and is currently the major cause of death in Australia2 accounting for over 43,600 deaths in […]
了解更多
Health systems in low and middle income countries continue to face considerable challenges in providing high-quality, affordable and universally accessible care – this is primarily evident in rural areas. As of 2014, approximately 876.1 million people live in rural areas within India with poor access to primary healthcare. This amounts to more than two-thirds of […]
了解更多
Over the years, technology within medical research has advance enormously, improving its methods of inputting and capturing data. When conducting clinical trials, it is crucial that current da […]
了解更多
New data presented at the American Society of Nephrology meeting in San Diego last November offers new hope to people with diabetes at risk of kidney disease and kidney failure. They suggest a new class of glucose-lowering agents, sodium glucose co-transporter type 2 (SGLT2) inhibitors, may be effective in preventing kidney failure. This data has […]
了解更多
Over the past years, the number of mobile phone subscribers in China has been increasing at an exponential rate. By the end of 2015, there was approximately 202.47 million cell phones produced in China1 along with 1,033.6 million mobile users registered in China, with the number of users expected to grow to 1,086.8 by 2019. […]
了解更多
Globally, there are millions of people that could benefit from an intensive lowering of blood pressure (BP). An individual with lower BP decreases their chances of suffering from any cardiovascular events such as: stroke, heart disease or heart attacks. A new study shows that lowering blood pressure to less than 140 mm Hg, the current […]
了解更多
Smartphones are changing our lives every day. Almost every industry is affected by the mobile revolution in one way or another. At 乔治临床( George Clinical ), we are in the business of clinical t […]
了解更多
乔治临床( George Clinical ) welcomes the development of the INVICTUS program which was launched at the World Heart Federation’s World Congress of Cardiology and Cardiovascular Health recently. The […]
了解更多
